Article
LAT1 enables T cell activation under inflammatory conditions: a new therapeutic target for…
bioRxiv · 2022 · Joy Ogbechi
Key facts
| Title | LAT1 enables T cell activation under inflammatory conditions: a new therapeutic target for rheumatoid arthritis |
|---|---|
| First author | Joy Ogbechi |
| Journal | bioRxiv |
| Published | Dec 20, 2022 |
| DOI | 10.1101/2022.12.20.520910 |
| Devices mentioned | K100803, K810180, K841331, K881004, K921179 |
| Product codes mentioned | FCX, FEB, FED, FEQ, NZA, GIA, JJH, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1